Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia
New acute myeloid leukemia research from Princess Margaret Hospital outlined
April 20th, 2008
According to recent research from Toronto, Canada, "Purpose of review Allogeneic stem cell transplantation is a potentially curative treatment for some high-risk patients with acute myeloid leukemia, but wider use of this treatment is limited by donor availability. Although use of alternative donors in these patients is increasing, the role of alternative donors in these high-risk patients, especially in first remission, remains undefined." "Recent findings Results of recent studies indicate that the outcomes with unrelated donors matched at allele levels (10/10) are similar to those in human leukocyte antigen identical sibling donor transplant recipients. Encouraging...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-20)
|
